Searched for
DRY AMD TREATMENT
Eyestem’s Eyecyte-RPE trial shows vision rescue for geographic atrophy patientsEyestem will be presenting its data at the ARVO 2025 Annual Meeting as well as the 10th Retinal Cell and Gene Therapy Innovation Summit in ...- Eyestem completes first set of patient injections for Dry AMD treatmentEyestem Research has completed the first set of patient injections for its RPE suspension therapy aimed at treating Dry age-related macular...
- Eyestem to begin human trials for its pioneering Dry AMD treatmentDry AMD, a leading cause of vision loss in the ageing population of people over 50, has long been a challenge due to the limited availabili...
- ‘Life’s Good’ when your vision is good: LG’s CSR initiative ‘Karein Roshni’ stresses eye care and its importanceGood vision is crucial for enhancing life quality. Dr Umang Mathur underlines the importance of eye care. Prevention of common eye diseases...
- Advancing stem cell therapy: The regulatory process to get to clinical trialsAdvancements in new drug and stem cell therapy can transform the treatment of many diseases, but development is complicated, takes years an...
- Eyestem partners with RetinAI for treatment of geographic atrophy with AI techGeographic atrophy can lead to irreversible loss of vision over time and currently affects 200 million people globally.
- Eyestem files for IND approval for its product to treat geographic atrophyEyestem Research has announced the submission of IND application to CDSCO to start first in-human trials of Eyecyte-RPE™for subjects.
- Eyestem announces US operations with appointment of Ravi Achar and engagement of Stradling advisorsEyestem has appointed Ravi Achar as Head- North America Strategy and also engaged Stradling Yocca Carlson & Rauth as its US law firm.
- Eyestem raises Series A round from Biological E, Alkem and othersThe investment will enable Eyestem to progress a treatment for Dry Age-related Macular Degeneration to the clinic.
- Cell therapy startup Eyestem raises ₹51 crore from BE, Alkem & NatcoExisting investors Endiya Partners and Kotak Private Equity also participated in this round, valuing Eyestem at $46.4 million (INR 371 Cror...
- Eyestem has a visionary approach to make cell therapy affordable in IndiaCell and gene therapy can go a long way in treating incurable diseases, but currently it is very pricey. Eyestem wants to dramatically cut ...
- Exploration results showing deposits of uranium, lithium, helium and Rare Earth Elements in Arunachal PradeshIt was also decided in the meeting that the state government, through its department of Geology and Mining, would collaborate with Atomic M...
- Do you experience flashes of light, distortion of images, cloudy vision? Screening for retinal diseases early can be beneficialIt is important for everyone to detect drop in vision at the earliest stage.
- Surgeons, a step closer to curing blindnessSurgeons in the UK have carried out a pioneering human embryonic stem cell operation in their efforts to find a cure for age-related blindn...
- Signs that could indicate a loss of visionHere's why ignoring that black spot floating in front of your eye could mean loss of vision.
- Sun & Intrexon JV for ocular diseasesThe joint venture will leverage Sun Pharma's global capabilities and experience in developing and manufacturing complex dosage forms and sp...
Load More
